“The global viral clearance market is projected to reach USD 510.3 million by 2020 from USD 285.5 million in 2015, at a CAGR of 12.3% from 2015 to 2020. The major drivers for the market include increase in pharmaceutical and biological industries and increasing number of new drug launches. Over the years, the number of drug approvals in North American countries has increased from 2006 to 2015. The increasing number of drug approvals will boost the viral clearance market.
This report segments the global viral clearance market is segmented based on method, end user, application, and geography. The method segments included in the report are viral detection method, viral removal method, and viral inactivation method. The viral detection method is further subsegmented in to plaque assays, PCR, ELISA, and other viral detection method. Other viral detection method includes western blot, transmission EM, in vivo assay, in vitro assay, and NGS (Next Generation Sequencing). The viral removal method is further subsegmented in to chromatography, nanofiltration, and precipitation. The viral inactivation method is further subsegmented in to solvent detergent method, pasteurization, and other viral inactivation method. Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.
The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.
Based on end user this market is categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes medical device companies, cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.
The geographic segments included in this report are Asia, Europe, North America and the Rest of the World (RoW). North America is further divided into Canada and the U.S.
The report provides qualitative insights on key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the viral clearance market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.
The report provides insights on the following:
â¢ Product Development/Innovation: Product portfolios of top players in the viral clearance market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the viral clearance market
â¢ Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the viral clearance market
â¢ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various viral clearance products across geographies
â¢ Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the viral clearance market